Nu Skin Enterprises (NUS) Competitors $12.09 +0.71 (+6.24%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$12.15 +0.06 (+0.50%) As of 08/22/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NUS vs. COTY, HLF, USNA, NATR, MED, VERU, EL, IPAR, PBH, and HELEShould you be buying Nu Skin Enterprises stock or one of its competitors? The main competitors of Nu Skin Enterprises include Coty (COTY), Herbalife (HLF), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), and Helen of Troy (HELE). Nu Skin Enterprises vs. Its Competitors Coty Herbalife USANA Health Sciences Nature's Sunshine Products MEDIFAST Veru Estee Lauder Companies Interparfums Prestige Consumer Healthcare Helen of Troy Coty (NYSE:COTY) and Nu Skin Enterprises (NYSE:NUS) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership. Do institutionals and insiders have more ownership in COTY or NUS? 42.4% of Coty shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 6.0% of Coty shares are held by insiders. Comparatively, 2.0% of Nu Skin Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, COTY or NUS? Coty has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Which has better earnings & valuation, COTY or NUS? Coty has higher revenue and earnings than Nu Skin Enterprises. Coty is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoty$5.89B0.58$89.40M-$0.48-8.16Nu Skin Enterprises$1.73B0.35-$146.59M$2.016.01 Does the media refer more to COTY or NUS? In the previous week, Coty had 74 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 79 mentions for Coty and 5 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.53 beat Coty's score of -0.03 indicating that Nu Skin Enterprises is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coty 10 Very Positive mention(s) 10 Positive mention(s) 28 Neutral mention(s) 16 Negative mention(s) 2 Very Negative mention(s) Neutral Nu Skin Enterprises 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is COTY or NUS more profitable? Nu Skin Enterprises has a net margin of 6.20% compared to Coty's net margin of -6.24%. Nu Skin Enterprises' return on equity of 8.23% beat Coty's return on equity.Company Net Margins Return on Equity Return on Assets Coty-6.24% 5.18% 1.70% Nu Skin Enterprises 6.20%8.23%4.05% Do analysts rate COTY or NUS? Coty currently has a consensus target price of $6.34, suggesting a potential upside of 61.86%. Nu Skin Enterprises has a consensus target price of $6.88, suggesting a potential downside of 43.13%. Given Coty's stronger consensus rating and higher possible upside, analysts plainly believe Coty is more favorable than Nu Skin Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coty 2 Sell rating(s) 13 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.11Nu Skin Enterprises 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryCoty beats Nu Skin Enterprises on 9 of the 16 factors compared between the two stocks. Get Nu Skin Enterprises News Delivered to You Automatically Sign up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUS vs. The Competition Export to ExcelMetricNu Skin EnterprisesCOSMETICS&TLTRS IndustryStaples SectorNYSE ExchangeMarket Cap$563.28M$3.29B$16.44B$20.94BDividend Yield2.11%2.22%3.10%3.58%P/E Ratio6.0118.6718.7229.17Price / Sales0.3519.9546.6772.56Price / Cash5.0717.4314.8823.54Price / Book0.763.775.815.47Net Income-$146.59M$37.46M$687.69M$992.74M7 Day Performance4.49%-1.38%0.56%2.67%1 Month Performance23.32%-7.92%-2.41%1.52%1 Year Performance20.90%-14.10%5.25%10.77% Nu Skin Enterprises Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUSNu Skin Enterprises4.2826 of 5 stars$12.09+6.2%$6.88-43.1%+26.3%$563.28M$1.73B6.013,100News CoverageAnalyst UpgradeCOTYCoty4.5642 of 5 stars$4.98+1.2%$7.80+56.6%-60.9%$4.29B$6.12B-10.3811,791Trending NewsEarnings ReportAnalyst ForecastOptions VolumeHLFHerbalife4.049 of 5 stars$9.18-4.5%$11.50+25.3%+16.1%$990.85M$4.99B2.908,600USNAUSANA Health Sciences4.4155 of 5 stars$30.31-0.3%$36.00+18.8%-18.3%$555.46M$854.50M16.841,700News CoveragePositive NewsNATRNature's Sunshine Products3.013 of 5 stars$16.47-0.4%$19.67+19.4%+24.8%$291.69M$454.36M22.26850MEDMEDIFAST3.6851 of 5 stars$13.41+1.7%$16.50+23.0%-24.9%$144.97M$602.46M41.91870VERUVeru2.4524 of 5 stars$3.51-2.2%$33.33+849.7%-56.9%$52.62M$16.89M-1.60230ELEstee Lauder Companies4.1588 of 5 stars$90.85-0.1%$86.95-4.3%-0.4%$32.73B$15.61B-37.5462,000Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionIPARInterparfums4.3101 of 5 stars$113.02+0.2%$162.00+43.3%-5.2%$3.62B$1.45B22.65530Trending NewsAnalyst RevisionPBHPrestige Consumer Healthcare4.6869 of 5 stars$64.93-0.1%$93.33+43.7%-5.8%$3.20B$1.14B15.24540HELEHelen of Troy3.0499 of 5 stars$23.13+0.3%$44.33+91.7%-52.8%$529.29M$1.91B-1.591,883News Coverage Related Companies and Tools Related Companies Coty Competitors Herbalife Competitors USANA Health Sciences Competitors Nature's Sunshine Products Competitors MEDIFAST Competitors Veru Competitors Estee Lauder Companies Competitors Interparfums Competitors Prestige Consumer Healthcare Competitors Helen of Troy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUS) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nu Skin Enterprises With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access